AURELIUS Acquires McKesson UK (including LloydsPharmacy and AAH Pharmaceuticals)

November 11, 2021

AURELIUS (AURELIUS Equity Opportunities / Aurelius Group) agreed to acquire McKesson’s UK businesses in November 2021, a transaction that included LloydsPharmacy and AAH Pharmaceuticals and was reported at roughly £477 million. The deal, a carve‑out from McKesson Corporation, was described by AURELIUS as the largest transaction in the company’s history and expands its healthcare services footprint in the United Kingdom.

Buyers
AURELIUS Equity Opportunities SE & Co. KGaA (Aurelius Group)
Targets
LloydsPharmacy, AAH Pharmaceuticals
Sellers
McKesson Corporation
Location
England, United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.